Fred Vogt
Interim CEO and General Counsel at Iovance Biotherapeutics, Inc.
Fred Vogt is a seasoned professional with expertise in intellectual property law, particularly in patent prosecution and litigation. His skill set extends to securities, corporate transactions, licensing, and antitrust law. With a background in biochemistry, biotechnology, chemistry, chemical engineering, materials science, and various branches of chemistry, including organic, analytical, physical, and quantum chemistry, Fred brings a diverse range of knowledge to his legal practice.
Fred Vogt
Interim CEO and General Counsel at Iovance Biotherapeutics, Inc.
Fred Vogt is a seasoned professional with expertise in intellectual property law, particularly in patent prosecution and litigation. His skill set extends to securities, corporate transactions, licensing, and antitrust law. With a background in biochemistry, biotechnology, chemistry, chemical engineering, materials science, and various branches of chemistry, including organic, analytical, physical, and quantum chemistry, Fred brings a diverse range of knowledge to his legal practice.